Woodmont Investment Counsel LLC Harrow Health, Inc. Transaction History
Woodmont Investment Counsel LLC
- $1.32 Billion
- Q3 2024
A detailed history of Woodmont Investment Counsel LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Woodmont Investment Counsel LLC holds 80,955 shares of HROW stock, worth $3.47 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
80,955
Previous 205,863
60.68%
Holding current value
$3.47 Million
Previous $4.3 Million
15.37%
% of portfolio
0.28%
Previous 0.33%
Shares
5 transactions
Others Institutions Holding HROW
# of Institutions
177Shares Held
21.4MCall Options Held
845KPut Options Held
717K-
Opaleye Management Inc. Boston, MA3.99MShares$171 Million32.75% of portfolio
-
Private Capital Management, LLC Naples, FL2.16MShares$92.8 Million11.41% of portfolio
-
Black Rock Inc. New York, NY2.15MShares$92.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$80.1 Million0.0% of portfolio
-
State Street Corp Boston, MA731KShares$31.4 Million0.0% of portfolio
About HARROW HEALTH, INC.
- Ticker HROW
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 27,070,000
- Market Cap $1.16B
- Description
- Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...